Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

NCT00372983 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cellectar Biosciences, Inc.